Comprehensive Immunological Study of Persons Vaccinated with Live Plague Vaccine Living on the Territory of the Pre-Caspian Sand Foci of the Plague in the Republic of Kalmykia

Relevance. In 2005 International Health Regulations, the plague, is on the list of dangerous infectious diseases that can cause emergency situations of interstate importance. Even single cases of human plague are considered as the basis for carrying out preventive measures. The paper presents the results of immunological monitoring conducted on the territory of the Republic of Kalmykia in order to assess the immunological efficacy and safety of the plague live vaccine The paper presents the results of immunological monitoring in the territory of the Kalmyk Republic over the individuals vaccinated against plague due to epidemiological reasons. Materials and methods. Studies of immunological efficacy of live plague vaccine were conducted alongside stepwise assessment of cellular and humoral components of innate and adaptive immunity in persons revaccinated against plague, using a complex of advanced informative tests. Results and conclusions. It is established that before the second revaccination all the surveyed persons retained expressed immune response by the mixed or cellular type, characterized by high level of spontaneous and induced production of Th1-associated cytokines. Activation of Th1 immune reaction was registered one month after the scheduled revaccination; immune response change-over from Th1 to Th2 type – after 6 months of observation, and retention of adaptive immunity by mixed type at the moderate level – in a year. Specific humoral immunity developed in 85% of the surveyed persons, but throughout the whole investigation the dynamics of antibody titers to plague microbe F1 individualized and did not coincide with cellular immunity indicators. Performed complex study has confirmed the relative safety of the live plague vaccine.

1. Popov N. V., Bezsmertny V. E., Matrosov A. N., Knyazeva T. V., Kuznetsov A. A., Fedorov Y. M. et al. Epizootic activity of natural plague foci in the territory of the Russian Federation in 2014 and prognosis for 2015. Problems of Particularly Dangerous Infections. 2015; 1: 10–17 (in Russian).

2. Popov N. V., Bezsmertny V. E., Matrosov A. N., Knayzeva T. V., Kuznetsov A. A., Fedorov U. M. et al. Epizootic activity of natural plague foci in the territory of the Russian Federation in 2015 and prognosis for 2016. Problems of Particularly Dangerous Infections. 2016; 1: 13–9 (in Russian).

3. Popova A. U., Kutyrev V. V., Ezhlova E. B., Demina U. V., Pakskina N. D., Shchuchinov L. V. et al. Coordination of measures of plague control institutions, aimed at rehabilitation and sanitation of Gorno-Altai high-mountain natural plague focus in 2016. Problems of Particularly Dangerous Infections. 2016; 4: 5–10 (in Russian).

4. Popov N. V., Matrosov A. N., Knayzeva T. V., Kuznetsov A. A., Fedorov U. M., Popov V. P. et al. Epizootic activity of natural plague foci in the territory of the Russian Federation in 2016 and prognosis for 2017. Problems of Particularly Dangerous Infections. 2017; 1: 5–12 (in Russian).

5. Sanitary rules 3.1.7.3465-17. Prevention of plague.

6. On the approval of the national calendar of preventive vaccinations and the calendar of preventive vaccinations for epidemiological indications. Order of the Ministry of Health of the Russian Federation No. 125n; 2014 (in Russian).

7. Odinokov G. N., Eroshenko G. A., Krasnov Y. M., Kukleva L. M., Cherkasov A. V., Shavina N. Y. et al. Analysis of the genome wide sequence of yersinia pestis strains based on the consecutive 680-snp algorithm. Problems of Particularly Dangerous Infections. 2013; 3: 49–54 (in Russian).

8. Bugorkova S. A., Devdariani Z. L., Shchukovskaya T. N., Kutyrev V. V. Historical and modern views on the problem of specific plague prophylaxis. problems of particularly dangerous infections. 2013; 3: 63-69 (in Russian).

9. Supotnitskiy M. V., Supotnitskaya N. C. Essays on the history of the plague. Moscow: The University Book; 2006 (in Russian).

10. Bogacheva N. V., Darmov I. V., Kucherenko A. S., Kryuchkov A. V., Vakhnov E. Y. Evaluation of immunoreactivity of persons vaccinated with plague, anthrax, brucellosis, tularemia live dry vaccine and botulinum antitoxin depending on the level of immunological stress. Epidemiology and Vaccinal Prevention. 2013; 6 (73): 79–84 (in Russian).

11. Bogacheva N. V., Kryuchkov A. V., Darmov I. V., Vorobiev K. A., Pechenkin D. V., Elagin G. D. et al. The experimental evaluation with flow cytofluorimetry technique of the level of cellular immunologic memory in persons vaccinated against plague and anthrax. Clinical laboratory diagnostics. 2013; 11: 48–53 (in Russian).

12. Firstova V. V., Kalmantaeva O. V., Gorbatov A. A., Kravchenko T. B., Tjurin E. A., Bondarenko N. L. Specific humoral and cellular immunity in humans periodically vaccinated against plague. Immunopathology, allergology, infectology. 2015; 3: 62–68 (in Russian).

13. Kulichenko A. N., Abzaeva N. V., Gostishcheva S. E., Rakitina E. L., Ponomarenko D. G., Kostyuchenko M. V. The antigen-specific cell in vitro tests for post-vaccination antiplague immunity formation. Russian Journal of Infection and immunity. 2017; 7 (2): 203–208 (in Russian).

14. Nafeev A. A., Savelyeva N. V., Sibaeva E. I. Immunological (serological) monitoring in the epidemiological surveillance system of natural – focal infections. Epidemiology and infectious diseases. 2016; 21 (5): 286–287 (in Russian).

15. Shchukovskaya T. N., Smolkova E. A., Shmelkova T. P., Klueva S. N., Bugorkova S. A. Induced production of IFN-γ and IL-4 as an indicator of functional activity human Th1 and Th2 cells after plague vaccination. Epidemiology and Vaccinal Prevention. 2011; 6 (61): 78–83 (in Russian).

16. Medical laboratory technologies. Directory. Karpischeva A.I. ed. St. Petersburg: Intermedica; 2002 (in Russian).

17. Clinical Immunology. Ed.: Karaulov A.V. Moscow: Medical News Agency; 1999 (in Russian).

18. Godkov M. A., Zinkin V. Y. Method of diagnosing the functional state of human neutrophils. Patent of the RF № 2218567; 2003 (in Russian).

19. Kudryavtseva O. M., Shchukovskaya T. N., Mikshis N. I., Klyueva S. N., Bugorkova S. A., Sandzhiev D. N. et al. Identification of HLA II class gene associations of the main histocompatibility complex with peculiarities of immune response in persons vaccinated with live plague vaccine in the republic of Kalmykia. Problems of Particularly Dangerous Infections. 2017; 3: 95–99. (in Russian)/ DOI:10.21055/0370-1069-2017-3-95-99.

20. Dalvadyants S. M., Dyatlov I. A., Eremin S. A., Kutyrev V. V. Studies on immunization against plague. Communication 2. Immunizing and revaccinating activity of drugs for specific prevention of plague in experiments on guinea pigs. Problems of Particularly Dangerous Infections. 2003; 86: 123–132 (in Russian).

21. Lyapina A. M., Fedorova V. A., Khizhnyakova M. A., Telepnev M. V., Motin V. L. Recombinant polypeptides as biomarkers for assessing the immunological efficacy of vaccination with live plague vaccine in humans. Medical academic journal. 2012; 12 (3): 85–87 (in Russian).

22. Dolgushin I. I., Bucharin O. V. Neutrophils and homeostasis. Ekaterinburg: Ural Branch of RAS; 2001 (in Russian).

23. Mayansky D. N. Lectures on clinical pathology. Moscow: GEOTAR-Media; 2008 (in Russian).